Criteria Used in Clinical Practice to Guide Immunosuppressive Treatment in Patients with Primary Sclerosing Cholangitis

BACKGROUND & AIMS: Current guidelines recommend immunosuppressive treatment (IT) in patients with primary sclerosing cholangitis (PSC) and elevated aminotransferase levels more than five times the upper limit of normal and elevated serum IgG-levels above twice the upper limit of normal. Since th...

Descripción completa

Detalles Bibliográficos
Autores principales: Schulze, Kornelius, Weismüller, Tobias J., Bubenheim, Michael, Huebener, Peter, Zenouzi, Roman, Lenzen, Henrike, Rupp, Christian, Gotthardt, Daniel, de Leuw, Philipp, Teufel, Andreas, Zimmer, Vincent, Reiter, Florian P., Rust, Christian, Tharun, Lars, Quaas, Alexander, Weidemann, Sören A., Lammert, Frank, Sarrazin, Christoph, Manns, Michael P., Lohse, Ansgar W., Schramm, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619354/
https://www.ncbi.nlm.nih.gov/pubmed/26489083
http://dx.doi.org/10.1371/journal.pone.0140525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619354/
https://www.ncbi.nlm.nih.gov/pubmed/26489083
http://dx.doi.org/10.1371/journal.pone.0140525

Ejemplares similares